Sr Director HEOR

Tolmar•Fort Collins, CO
•$300,000 - $325,000

About The Position

The Senior/Executive Director, Outcomes Research (Health Economics and Outcomes Research – HEOR) is a strategic leader responsible for developing and executing outcomes research strategies across the oncology portfolio, including solid tumors and hematologic malignancies. The role generates real-world evidence and health economic data to support product value, regulatory strategy, and market access, and translates clinical, epidemiologic, and economic insights into evidence for oncologists, payers, health systems, and policy stakeholders. The role owns integrated evidence planning for pipeline, commercial, and potential business-development assets; leads real-world evidence research and health-economic modeling; develops payer- and HTA-ready value materials; and oversees scientific communication. It also builds the HEOR/RWE function, including its operating model, governance, team, vendor relationships, and evidence budget. The position works cross-functionally with Clinical Development, Medical Affairs, Market Access, Pricing, and Commercial teams, and ensures that evidence activities meet applicable scientific, regulatory, privacy, legal, and compliance expectations. Travel up to 30%.

Requirements

  • Advanced degree required (PhD, MD, or MPH) in a relevant scientific discipline.
  • 12+ years of experience in HEOR, Market Access, or Medical Affairs within the pharmaceutical or biotech industry.
  • Demonstrated expertise in epidemiology and biostatistics related to study design and analysis.
  • Deep expertise in oncology outcomes research methodologies, clinical endpoints, and real-world evidence generation.
  • Advanced knowledge of HEOR study design, observational research, comparative effectiveness research, epidemiology, patient-reported outcomes, and oncology health-economic modeling.
  • Strong understanding of oncology treatment landscapes, standards of care, and competitive dynamics.
  • Demonstrated ability to develop integrated evidence-generation plans aligned with clinical development, medical affairs, market access, regulatory, and commercial objectives.
  • Strong understanding of payer, HTA, and reimbursement requirements, including evidence needs for value dossiers, formulary decisions, and coverage discussions.
  • Ability to evaluate and apply real-world data sources, including claims, EHRs, registries, chart reviews, and oncology-specific datasets.
  • Familiarity with relevant datasets in the US and abroad, including their distinct characteristics and implications for analysis choices.
  • Ability to critically assess scientific literature, clinical trial data, treatment guidelines, and external evidence to inform research priorities and strategic recommendations.
  • Excellent leadership, coaching, and talent-development skills, including the ability to build, mentor, and retain high-performing scientific teams.
  • Strong project-management and prioritization skills for managing studies, vendors, budgets, timelines, and cross-functional deliverables.
  • Knowledge of applicable regulatory, legal, privacy, publication, and compliance requirements related to outcomes research, RWE, and external stakeholder engagement.
  • Strong executive presence and communication skills, including the ability to explain complex methods and economic results clearly and influence senior and external stakeholders.
  • Ability to manage multiple studies, vendors, and budgets against launch-critical timelines.

Nice To Haves

  • Oncology experience, with demonstrated success in evidence generation and payer engagement.
  • Experience with physician-administered, buy-and-bill products and Part B or commercial medical-benefit economics.
  • Experience in a smaller or growing company building a function.
  • Exposure to ICER assessments, NCCN or pathway submissions, and IDN or oncology-practice value discussions.
  • Patient-reported outcomes and preference-research experience; familiarity with women’s health or survivorship populations.
  • Experience supporting portfolio or business-development evaluations with evidence assessments.

Responsibilities

  • Define and lead oncology-specific HEOR strategy across pipeline and in-line therapies, incorporating relevant endpoints such as overall survival, progression-free survival, and quality of life.
  • Build and maintain Integrated Evidence Plans for Phase 3 products, commercial assets, and business-development assets; assess evidence gaps and prioritize a sequenced, budgeted study portfolio.
  • Design and lead retrospective and prospective real-world evidence studies, including research on healthcare resource utilization, cost of care, treatment patterns, outcomes, and comparative effectiveness.
  • Evaluate and contract real-world data sources and establish standards for data quality, fitness for purpose, and bias control.
  • Develop study protocols and statistical analysis plans using advanced methods, consistent with applicable FDA guidance and ISPOR/ISPE good practices.
  • Lead patient-centered outcomes research, including patient-reported outcomes, treatment burden, treatment preferences, and quality-of-life evidence.
  • Scope pragmatic, registry, and investigator-initiated research with Medical Affairs and academic centers.
  • Direct development of US budget impact and cost-effectiveness models and adapt them for payer, employer, IDN, oncology practice, and pathway audiences.
  • Own the AMCP Format dossier and pre-approval information exchange materials, coordinating FDA guidance and Legal/Compliance review.
  • Prepare for external value assessments such as ICER and support compendia, NCCN, and pathway submissions with Medical Affairs.
  • Partner with Market Access and Pricing on evidence-informed pricing, contracting, and site-of-care economics while maintaining scientific independence.
  • Own the HEOR/RWE publication plan and develop abstracts, posters, and manuscripts for relevant scientific forums.
  • Represent the company as a scientific voice on evidence with payers, HTA bodies, KOLs, and data partners; support field medical and account teams with approved, fair-balanced evidence resources.
  • Build a scientific advisory network of outcomes researchers and breast oncology clinicians.
  • Build the HEOR/RWE function, including its operating model, SOPs, study review and approval process, and data governance.
  • Recruit, lead, and develop a team across RWE science, health economics, and analytics; balance in-house capabilities with specialized vendors.
  • Select and manage HEOR consultancies, real-world data providers, and CROs; manage the evidence budget and deliver studies on time and within budget.
  • Ensure evidence activities comply with FDA, OIG, PhRMA Code, privacy, data-use, and other applicable requirements, maintaining separation between scientific exchange and promotion.
  • Lead and develop a high-performing oncology HEOR team and influence senior leaders and external stakeholders through clear, data-driven communication.

Benefits

  • Bonus eligible
  • Benefits package; details provided at the company benefits webpage

Stand Out From the Crowd

Upload your resume and get instant feedback on how well it matches this job.

Upload and Match Resume

What This Job Offers

Job Type

Full-time

Career Level

Senior

Education Level

Ph.D. or professional degree

© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service